Gyre Therapeutics (GYRE) Total Debt (2016)
Historic Total Debt for Gyre Therapeutics (GYRE) over the last 8 years, with Q3 2016 value amounting to $28000.0.
- Gyre Therapeutics' Total Debt fell 9585.8% to $28000.0 in Q3 2016 from the same period last year, while for Sep 2016 it was $28000.0, marking a year-over-year decrease of 9585.8%. This contributed to the annual value of $1.2 million for FY2015, which is N/A changed from last year.
- Gyre Therapeutics' Total Debt amounted to $28000.0 in Q3 2016, which was down 9585.8% from $130000.0 recorded in Q2 2016.
- Over the past 5 years, Gyre Therapeutics' Total Debt peaked at $2.7 million during Q1 2012, and registered a low of $28000.0 during Q3 2016.
- Over the past 5 years, Gyre Therapeutics' median Total Debt value was $1.1 million (recorded in 2013), while the average stood at $1.2 million.
- As far as peak fluctuations go, Gyre Therapeutics' Total Debt surged by 4142.26% in 2015, and later plummeted by 9585.8% in 2016.
- Over the past 5 years, Gyre Therapeutics' Total Debt (Quarter) stood at $2.0 million in 2012, then crashed by 42.83% to $1.1 million in 2013, then crashed by 57.92% to $478000.0 in 2014, then skyrocketed by 141.84% to $1.2 million in 2015, then tumbled by 97.58% to $28000.0 in 2016.
- Its Total Debt was $28000.0 in Q3 2016, compared to $130000.0 in Q2 2016 and $196000.0 in Q1 2016.